Delivery Order SPE2DB20D2104-SPE2DB22FU08U
- Not listed
- This federal contract award is a $1,367.87 delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Risperdal 1 mg tablets, a mental health medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,876.95 firm fixed-price delivery order contract is for the supply of Risperdal 2 mg tablets. The contract has an ultimate completion date of January 25, 2024. This award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,682.65 firm-fixed-price delivery order is for the supply of Risperdal 1 mg tablets, a pharmaceutical product used for mental health treatment. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,759.83 firm fixed-price delivery order contract is to supply Risperdal 1 mg tablets to support military healthcare programs. The contract has an ultimate completion date of November 14, 2024. While the original solicitation was not provided, the award indicates that it was not designated with any set-aside...
- This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,275.72 firm-fixed-price contract is for the delivery of Risperdal 3 mg tablets, a mental health medication, with an ultimate completion date of October 24, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support...
- This federal contract award, valued at $1,573.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Risperdal 2 mg tablets. It is a Firm Fixed Price, Delivery Order type contract with a completion date of June 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Risperdal 1 mg tablets, a mental health medication, for $1,023.97. The contract has a period of performance ending on June 30, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,062.01 Firm Fixed Price delivery order contract is for the supply of RISPERDAL 2 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025 and was awarded on July 16, 2025. It is not a set-aside contract. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,774.47 firm fixed-price delivery order is for the supply of 4,559,430 units of Risperidone 1 mg tablets, a medication used to treat mental health conditions. The order has an ultimate completion date of December 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,400.27 firm fixed-price delivery order is for the supply of 60 count packages of 2 mg Risperidone tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024 with no set-aside designation, indicating open...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FU08UDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,382.54 firm fixed-price delivery order is for the supply of Risperdal 2 mg tablets, a medication commonly used for the treatment of mental health conditions. The contract, which has an ultimate completion date of September 29, 2022, is not designated as a set-aside. It is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 9/28/22 |